0.6931USD-2.38%Mkt Cap: 10.31M USDP/E: —Last update: 2026-05-26
Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class …
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap10.31M USD
Enterprise Value6.81M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.85M USD
Revenue/Share—
Last Price0.6931 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.81
EV/Revenue—
P/S—
P/B-2.74
EPS (TTM)-0.28
EPS (Forward)—
52W Range
0.66000% of range9.820
52W High9.820 USD
52W Low0.6600 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE195.85%
ROA-798.93%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.94M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-5.10%
Net Debt1.42M USD
Net Debt/EBITDA-0.38
Balance Sheet
Debt/Equity-0.85
Current Ratio0.13
Quick Ratio0.10
Book Value/Sh-0.2810 USD
Cash/Share0.0340 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.14.02M
Float2.83M
Insiders59.51%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Float1.01%
Short % Out.0.53%
Shares Short75.71K
Technical
SMA 503.107 (-77.7%)
SMA 2003.107 (-77.7%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)4.28M
Avg Vol (10d)4.25M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—